Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 CAD | 0.00% | +3.47% | -16.76% |
Apr. 11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
Apr. 11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Jon Patton
IRC | Investor Relations Contact | - | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
James Parsons
BRD | Director/Board Member | 58 | 22-06-15 |
Angela Holtham
BRD | Director/Board Member | 73 | 14-06-17 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Wayne Pisano
CHM | Chairman | 69 | 13-05-08 |
Deborah Brown
BRD | Director/Board Member | - | 17-11-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,419,768 | 72,478,872 ( 96.10 %) | 0 | 96.10 % |
Company contact information
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.76% | 82.03M | |
+1.94% | 42.59B | |
+8.35% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.82% | 24.81B | |
-24.19% | 18.17B | |
+28.83% | 12.05B | |
-2.99% | 11.7B | |
+6.99% | 11.1B |
- Stock Market
- Equities
- ONC Stock
- Company Oncolytics Biotech Inc.